Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
about
Antiplatelet resistance in strokeDrug interactions--principles, examples and clinical consequencesImpact of proton pump inhibitors on efficacy of clopidogrel: Review of evidenceClopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designsOverutilization of proton-pump inhibitors: what the clinician needs to knowPrevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxisDiagnosis and therapy of non-variceal upper gastrointestinal bleedingPharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic reviewHigh residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistanceClopidogrel and proton pump inhibitors--where do we stand in 2012?Current perspectives in NSAID-induced gastropathyEsomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsExpert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapyProton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuriesPharmacokinetic drug-drug interaction and their implication in clinical managementPharmacokinetic drug interaction profiles of proton pump inhibitors: an updatePotential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospitalEffects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort StudyProton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General PopulationImpact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.Clopidogrel: the data, the experience, and the controversies.Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement.Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study.Recent advances in antithrombotic therapy after acute coronary syndrome.Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndromeThe risk of endoscopic mucosal resection in the setting of clopidogrel use.Clopidogrel and proton pump inhibitors: a new drug interaction?Modern role for clopidogrel in management of atrial fibrillation and stroke reductionThe potential interaction between clopidogrel and proton pump inhibitors: a systematic review.The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stentingRisk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsCombined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapyRecent advances in peptic ulcer bleeding.Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics.'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty.Association between proton pump inhibitor use and anemia: a retrospective cohort study.Adverse effects of long-term proton pump inhibitor therapy.
P2860
Q22305927-63F8ED78-F1EE-4BFC-A7BF-F3ED477CFC83Q24599421-292D921F-E1B5-43F4-8460-B861549EDE9CQ24608981-0D8AD751-9272-41AD-A30D-EDEF455A2DE1Q24633087-9A619778-1842-4B9D-A305-AEC6B1620CF1Q24634086-EFFD0473-5930-4841-BBBE-94117111E1D8Q26768234-9BA8C81A-2512-4973-AB56-62A6DE627EADQ26777626-AD85D87D-95C1-4D9E-8371-4A70638EA562Q26822474-F0751F7C-035F-41DB-9089-1CAA9AEB130AQ26824850-6D9B3450-6C18-4DE1-96A4-AC9851F261D1Q26825728-BF823DED-F00A-47F7-AA4F-D0C3EE796C9BQ26827673-91217782-1E2B-43BE-8B6B-D9CFADAA6F78Q26995752-E1138942-297E-48FF-A7D1-80510CB63921Q26998331-3C7F5208-B456-416B-8AA4-B142F92500BAQ27004834-77609499-240D-4ADF-8988-B192E7C733C2Q27021051-C8856BBE-94EC-4EAB-A6E7-7D912D86C157Q27022254-9ECECAA5-FA44-41D3-BA78-8B7E75B1EC81Q28480623-F1F79CF3-DDBC-4E3A-9801-A61124D05A62Q28547539-F95A7342-5C28-4FE8-9504-632BE031D810Q28548045-DE4E80C9-6795-482D-906B-69354999C44AQ30421742-D0F3768B-3AAF-4EFD-850A-973319FD2C98Q30573045-2631C94A-1024-4DB5-B0E8-7AC621EDAD76Q33554381-D63A8B53-6FB4-4822-B8B8-0C6F4EA1AB63Q33583991-BF4367DC-F42B-4715-8103-D9529C9B2B62Q33590548-C54B631E-4A94-48FD-97FC-FE0D393EEA40Q33639452-99E10C2A-AC80-473D-9155-84A500E9C26BQ33692737-1C14E3B0-95D2-491D-BB47-ECC8C140B973Q33705305-12C8FD42-8DAE-49A6-BA2D-19E5098D11DCQ33715413-0F033035-C9C6-4FFF-871A-071BDF3FB66CQ33763929-AFA1D80C-C194-4088-AAF1-E968550F61D4Q33776115-60F9ADAC-663D-4CEE-9667-A5AC9F3A12B8Q33849056-61F9716F-398E-4BA4-AABA-BB18538C0B7CQ33949498-BB243DAB-BA1F-4CA8-A117-8F1E32C23078Q33997642-2209EC71-9D64-4247-8C86-A3D0355BA0B7Q34019082-15EE7AAA-2680-4CC1-AEA8-2B6742BA9792Q34076408-4272D0E7-FBAA-4C72-8BCB-0E93A9EED92CQ34104550-21CDF236-3990-40AF-AF6D-735008E08B62Q34135274-B3E06089-A4B7-4C02-B0FF-F635176239AFQ34150640-080E3436-38EA-48AB-AE3C-7380D45B03A8Q34164370-627D86A8-BAB9-4B42-92AF-C36005C64A1AQ34167899-D62D1785-22D1-43C7-BE26-4CA112743645
P2860
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@ast
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@en
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@nl
type
label
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@ast
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@en
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@nl
prefLabel
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@ast
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@en
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@nl
P2093
P356
P1476
Risk of adverse outcomes assoc ...... owing acute coronary syndrome.
@en
P2093
John S Rumsfeld
P Michael Ho
Robert L Jesse
Stephan D Fihn
Thomas M Maddox
P304
P356
10.1001/JAMA.2009.261
P407
P577
2009-03-01T00:00:00Z